The largest database of trusted experimental protocols

Dmt chemically competent cells

Manufactured by Transgene
Sourced in China

DMT chemically competent cells are a type of laboratory equipment used for the transformation of plasmid DNA into bacterial host cells. They are designed to facilitate the uptake of foreign DNA into competent cells, enabling the cells to express the desired genetic material. The core function of DMT chemically competent cells is to provide a reliable and efficient method for introducing DNA into bacterial hosts for various molecular biology applications, such as gene cloning, protein expression, and genetic engineering.

Automatically generated - may contain errors

4 protocols using dmt chemically competent cells

1

Pichia pastoris Lipase Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pichia pastoris GS115 was from Invitrogen (Shanghai, China). A site-directed mutagenesis kit and DMT chemically competent cells were from TransGen (Beijing, China). The R. chinensis lipr27RCL gene cloned in the pPIC9K vector was deposited in our laboratory. We obtained 4-nitrophenol palmitate (4-NPP) from Sigma. Mutagenic primers were synthesized by Shuoqing (Kunming, China). All other chemicals were commercially available analytical grade materials.
+ Open protocol
+ Expand
2

Dimerization analysis of sulfatase mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze if the N-terminal Cys residue contributed to the dimerization of the sulfatase, the mutants of endoVB4SF-C27A and corresponding exoPB4SF-Q5C were produced using a Fast Mutagenesis System Kit (TransGen) as previously described by Prabhakar et al. (2005) (link) The plasmids were amplified using the primer pairs 5′-ATGGTGACTGCTGGCGCGTCGGCTAC-3′ (forward, endoVB4SF-C27A) and 5′-CGCGCCAGCAGTCACC ATGGTTGC-3′ (reverse, endoVB4SF-C27A), and 5′-TTCTTGA CGGGCAATTGCCCCGCTG-3′ (forward, exoPB4SF-Q5C) and 5′-GCAATTGCCCGTCAAGAATTCGGATCCG-3′ (reverse, exoPB4SF-Q5C). The plasmids of the mutants were amplified by transferring them to DMT Chemically Competent Cells (TransGen), and mutated clones were confirmed by DNA sequencing at Sangon Biotech Co., Ltd. (Shanghai, China). Next, the correct mutants were transferred into E. coli BL21 (DE3) cells. endoVB4SF-C27A and exoPB4SF-Q5C were expressed and purified as described above for the wild-type enzyme.
The purified endoVB4SF, exoPB4SF, endoVB4SF-C27A and exoPB4SF-Q5C proteins were detected at 280 nm through size-exclusion chromatography (SuperdexTM 200 10/300 GL, GE Healthcare) eluted with buffer (10 mM Tris-HCl and 100 mM NaCl, pH 8.0) with or without 5 mM DTT.
+ Open protocol
+ Expand
3

Site-Directed Mutagenesis of sTAAR365 and mTAAR9

Check if the same lab product or an alternative is used in the 5 most similar protocols
Site-directed mutations of sTAAR365 and mTAAR9 were introduced following the protocol of Quik Change site-directed mutagenesis kit (Agilent Technologies). In brief, PCR primers were designed by Agilent QuikChange Primer Design (Tables S3 and S4) and PCR reactions were performed using PfuUltra High-Fidelity DNA Polymerase with wild-type sTAAR365 and mTAAR9 plasmids as templates. The methylated parental strands were selectively digested with 1 μl DpnI enzyme, and the DpnI-treated PCR products were transformed into DMT chemically competent cells (Transgen Biotech). All mutants were verified by DNA sequencing. Positive colonies for the desired substitutions were grown in LB broth and the plasmids were isolated using an EndoFree mini plasmid DNA purification kit (Tiangen Biotech).
+ Open protocol
+ Expand
4

Structural Analysis and Mutagenesis of PB2SF

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protein sequence of PB2SF was uploaded, and a three-dimensional model of PB2SF was built by the protein structure homology-modeling server SWISS-MODEL online1 (Biasini et al., 2014 (link)) using the structure of bacterial 2-O-sulfatase BT_1596 as a template (PDB code: 3b5q) (Ulmer et al., 2014 (link)). Structural figures were created and rendered using the program PyMOL (Schrödinger LLC2).
Mutants of PB2SF were produced by using the Fast Mutagenesis System Kit (TransGen) as described by Prabhakar et al. (2005) (link). The primer sequences used for the mutations are presented in Table 2. The plasmids of the mutants were amplified by transferring them to DMT Chemically Competent Cells (TransGen), and clones were sequenced at Sangon Biotech, Co., Ltd. (Shanghai, China) to confirm the successful introduction of the mutations. Then, correct plasmids were transferred into E. coli BL21 (DE3) cells and expressed, and the enzymatic activity of the mutants was determined under optimum conditions [50 mM HAc-NaAc buffer (PH 6.0), 40°C], as described above for the wild-type enzyme PB2SF.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!